Bluestar Adisseo (600299.SH) announced its 2024 interim report, achieving a revenue of 7.261 billion yuan in the first half of the year, a year-on-year increase of 14.74%; achieving a net profit attributable to shareholders of listed companies of 0.608 billion yuan, a year-on-year increase of 1,719.14%; achieving a net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses of 0.705 billion yuan, a year-on-year increase of 6,522.57%; and basic earnings per share of 0.23 yuan.

In the first half of 2024, the significant year-on-year growth in net profit attributable to shareholders of listed companies and net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses is mainly due to the following factors: 1) strong growth in methionine business; 2) continued stable development of specialty products business, especially the stable growth of monogastric animal products and aquatic products, offsetting the adverse effects of the sluggish North American dairy market; 3) positive effects brought by the continuous optimization of raw material costs, energy costs, global supply chains, distribution, and tariff management; 4) continued strict working capital management and ongoing cost control measures and competitiveness enhancement plans.